SBA-16 modified with n-propyl-salicylaldimine (–NH2) |
Cu2+ (58 mg/g, 4, room) |
Experimental |
[168] |
Co2+ (16 mg/g, 4, room) |
Experimental |
SBA-16 modified with n-propyl-salicylaldimine and salicylaldehyde (–N=) |
Cu2+ (15.2 mg/g, 4, room) |
Experimental |
– |
Co2+ (4.5 mg/g, 4, room) |
Experimental |
SiO2 modified with n-propyl-salicylaldimine (–NH2) |
Cu2+ (45.2 mg/g, 4, room) |
Experimental |
– |
Co2+ (11.2 mg/g, 4, room) |
Experimental |
SiO2 modified with n-propyl-salicylaldimine and salicylaldehyde (–N=) |
Cu2+ (10.2 mg/g, 4, room) |
Experimental |
– |
Co2+ (3.6 mg/g, 4, room) |
Experimental |
3-Aminopropyl-functionalized MCM-41 (ammonium group) |
Arsenate (64.4 mg/g, 3–4,room) |
Experimental |
[169] |
Chromate (52.9 mg/g, 7–8,room) |
Experimental |
3-Aminopropyl-functionalized SBA-1 (ammonium group) |
Arsenate (94.2 mg/g, 3–4,room) |
Experimental |
– |
Chromate (132.7 mg/g, 7–8,room) |
Experimental |
H2N–(CH2)2–NH–(CH2)3–functionalized SBA-15 (–NH2 and –NH–) |
Cu2+ (0.83 mmol/g, neutral, 25) |
Langmuir |
[170] |
3-Aminopropyl-functionalized SBA–15–N–C–H (–NH2) |
Cu2+ (0.39 mmol/g, neutral, 25) |
Langmuir |
– |
3-Aminopropyl-functionalized SBA–15–N–E (–NH2) |
Cu2+ (0.35 mmol/g, neutral, 25) |
Langmuir |
– |
3-Aminopropyl-functionalized SBA–15–N–C (–NH2) |
Cu2+ (0.24 mmol/g, neutral, 25) |
Langmuir |
– |
3-(2-Aminoethylamino) propyltrimethoxysilane modified ordered mesoporous silica |
As(V) (10.3 mg/g, 7, room) |
Experimental |
[171] |
N-propyl aniline-functionalized MCM-41 (–NH–) |
Arsenate (0.85 mmol/g, 4.2, room) |
Experimental |
[172] |
Hg2+ (0.92 mmol/g, 3.5, room) |
Experimental |
Pb2+ (0.78 mmol/g, 5.8, room) |
Experimental |
H2N–functionalized SBA-15 (–NH2) |
Cu2+ (1.28 mg/g, neutral, room) |
Experimental |
[173] |
Pb2+ (1.31 mg/g, neutral, room) |
Experimental |
Cd2+ (1.35 mg/g, neutral, room) |
Experimental |
Imidazole-functionalized SBA-15 (N atoms of imidazole) |
Pd2+ (0.091 mmol/g, 4, room) |
Experimental |
[174] |
Pt2+ (0.091 mmol/g, 4, room) |
Experimental |
SBA-15 modified with 3-aminopropyl-triethoxysilane and salicylaldehyde (–N= and –O− groups) |
Cu2+ (46 mg/g, 4.8, room) |
Experimental |
[175] |
Ni2+ (22 mg/g, 4.8, room) |
Experimental |
Co2+ (19 mg/g, 4.8, room) |
Experimental |
Zn2+ (26 mg/g, 4.8, room) |
Experimental |
Amino-functionalized mesoporous silica (–NH2 and –OH) |
Ni2+ (2.48 mmol/g, 8.5, 25) |
Sips |
[176] |
2-Mercaptopyrimidine-functionalized SBA-15 (N and S atoms) |
Cd2+ (0.99 mmol/g, 6, 25) |
Experimental |
[177] |
3-Aminopropyl-functionalized MCM-41 (–NH2) |
Au3+ (0.4 mmol/g, 2.5, room) |
Experimental |
[178] |
NH(propyl)-functionalized MCM-41 (–NH–) |
Au3+ (0.33 mmol/g, 2.5, room) |
Experimental |
– |
N(propyl)2-functionalized MCM-41 (N atom of amine group) |
Au3+ (0.2 mmol/g, 2.5, room) |
Experimental |
– |
Chemically modified MCM-41 (–NH– and –NH2) |
Hg2+ (0.7 mmol/g, 5, 25) |
Langmuir |
[179] |
3-Aminopropyl-functionalized MCM-41 (–NH2) |
Ag+ (0.62 mmol/g, 5, 22) |
Experimental |
[180] |
Cu2+ (0.84 mmol/g, 5, 22) |
Experimental |
3-Mercaptopropyl-functionalized MCM-41 (–SH) |
Ag+ (0.97 mmol/g, 5, 22) |
Experimental |
– |
Cu2+ (0.02 mmol/g, 5, 22) |
Experimental |
3-Mercaptopropyl-functionalized SBA-16 (–SH) |
Cu2+ (36.42 mg/g, 5.5, 25) |
Langmuir |
[181] |
3-Aminopropyl-modified SBA-15 (–NH2) |
Cu2+ (73.5 mg/g, 6.3, 25) |
Langmuir |
[182] |
SBB or N-((trimethoxysilyl)propyl)-N,N,N-tri-n-butylammonium chloride-functionalized SBA-15 (quaternary ammonium) |
ReO4− (1.85 mmol/g, 6.4, room) |
Experimental |
[183] |
3-Aminopropyl and 3-mercaptopropyl bi-functionalized mesoporous silica (–SH) |
Hg2+ (1.51 mmol/g, neutral, room) |
Experimental |
[184] |
Meso-structured silica modified with 3-mercaptopropyltrimethoxy silane and 9-(chloromethyl)anthracene (–SH) |
Pb2+ (13.96 mg/g, neutral, 25) |
Experimental |
[185] |
Cu2+ (12.56 mg/g, neutral, 25) |
Experimental |
Hg2+ (12.09 mg/g, neutral, 25) |
Experimental |
Zn2+ (3.69 mg/g, neutral, 25) |
Experimental |
3-Mercaptopropyl-functionalized SBA-15 (–SH) |
Hg2+ (2.88 mmol/g, 4.5, 20) |
Langmuir |
[186] |
Ordered mesoporous silica modified with 2,5-dimercapto-1,3,4-thiadiazole (–SH) |
Hg2+ (1.7 g/g, neutral, room) |
Experimental |
[187] |
1-Benzoyl-3-propylthiourea-functionalized MCM-41 (=N, =O, –NH– and –NH2 groups) |
Hg2+ (1 g/g, neutral, room) |
Experimental |
[188] |
Disulfide-bridged periodical mesoporous organosilica (–S–S–) |
Hg2+ (716 mg/g, 2, room) |
Experimental |
[189] |
3-Mercaptopropyl-functionalized MCM-41 (–SH) |
Hg2+ (0.59 mmol/g, neutral, room) |
Experimental |
[36] |
3-Mercaptopropyl-functionalized HMS (–SH) |
Hg2+ (1.5 mmol/g, neutral, room) |
Experimental |
– |
Mesoporous thioether-functionalized polyvinylpyrrolidone (PVP)/SiO2 composite (–S–) |
Hg2+ (4.26 mmol/g, 2, room) |
Experimental |
[190] |
Disulfide-functionalized SBA-1 (–SH) |
Hg2+ (849 mg/g, 2, room) |
Experimental |
[191] |
3-(((5-ethoxybenzenethiol)imino)methyl)-salicylic acid immobilized onto mesoporous silica (–N= and –SH groups) |
Pd2+ (164.2 mg/g, 3, room) |
Langmuir |
[192] |
3-(3-(Methoxycarbonyl)benzylidene) hydrazinyl)benzoic acid immobilized onto mesoporous silica (C=O and –N=NH–) |
Cu2+ (145.98 mg/g, 7, room) |
Langmuir |
[193] |
3-(2-Aminoethylamino)propyl-functionalized mesoporous silica (–NH– and –NH2) |
Cu2+ (0.107 mmol/g, 3, room) |
Experimental |
[194] |
3-Aminopropyl-functionalized MCM-41 (–NH2) |
Cd2+ (0.71 mmol/g, 5, 22) |
Experimental |
[195] |
Ni2+ (0.69 mmol/g, 5, 22) |
Experimental |
Diamino-functionalized MCM-41 |
Co2+ (0.69 mmol/g, neutral, 25) |
Experimental |
[196] |
Ni2+ (0.52 mmol/g, neutral, 25) |
Experimental |
Diamino-functionalized MCM-48 |
Co2+ (1 mmol/g, neutral, 25) |
Experimental |
– |
Ni2+ (0.86 mmol/g, neutral, 25) |
Experimental |
Aminopropyl grafted SBA-15 modified with EDTA (–NH– and –COO−) |
Pb2+ (273.2 mg/g, 5, 25) |
Langmuir |
[197] |
CONH2-functionalized SBA-15 (CONH2 group) |
Cu2+ (1.4 mmol/g, 5, 298) |
Langmuir |
[198] |